| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cutting Edge |
,
Departments of
*
Pathology,
Pediatrics, and
Microbiology and Molecular Genetics, Harvard Medical School; and
The Center for Blood Research, Boston, MA 02115
HSV-1 is the causative agent of cutaneous lesions, commonly referred to as cold sores. Primary exposure to the virus ordinarily occurs through the periphery, in particular through abraded skin or mucosal membranes. Under certain circumstances (e.g., in neonatals or AIDS patients), the infection becomes disseminated, often with severe consequences. Spread of HSV-1 is limited by virus-specific Ab. The development of an efficient humoral response to the virus is dependent on innate immunity component complement C3. The liver is the major source of C3, but there are also extrahepatic origins of C3 such as lymphoid macrophages. In the present study, the significance of C3 synthesis by bone marrow-derived cells was assessed by the transfer of wild-type bone marrow into irradiated C3-deficient mice. Using these chimeric mice, extrahepatic C3 was determined sufficient to initiate specific Ab and memory responses to a peripheral HSV-1 infection.
This article has been cited by other articles:
|
|
 |
|
  N. M. Girgis, B. C. DeHaven, X. Fan, K. M. Viner, M. Shamim, and S. N. Isaacs Cell Surface Expression of the Vaccinia Virus Complement Control Protein Is Mediated by Interaction with the Viral A56 Protein and Protects Infected Cells from Complement Attack J. Virol., May 1, 2008; 82(9): 4205 - 4214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Chung, M. K. Liszewski, G. Nybakken, A. E. Davis, R. R. Townsend, D. H. Fremont, J. P. Atkinson, and M. S. Diamond From the Cover: West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H PNAS, December 12, 2006; 103(50): 19111 - 19116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Brockman, A. Verschoor, J. Zhu, M. C. Carroll, and D. M. Knipe Optimal Long-Term Humoral Responses to Replication-Defective Herpes Simplex Virus Require CD21/CD35 Complement Receptor Expression on Stromal Cells J. Virol., July 15, 2006; 80(14): 7111 - 7117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Mehlhop and M. S. Diamond Protective immune responses against West Nile virus are primed by distinct complement activation pathways J. Exp. Med., May 15, 2006; 203(5): 1371 - 1381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Mehlhop, K. Whitby, T. Oliphant, A. Marri, M. Engle, and M. S. Diamond Complement Activation Is Required for Induction of a Protective Antibody Response against West Nile Virus Infection J. Virol., June 15, 2005; 79(12): 7466 - 7477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Judson, J. M. Lubinski, M. Jiang, Y. Chang, R. J. Eisenberg, G. H. Cohen, and H. M. Friedman Blocking Immune Evasion as a Novel Approach for Prevention and Treatment of Herpes Simplex Virus Infection J. Virol., December 1, 2003; 77(23): 12639 - 12645. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Verschoor, M. A. Brockman, M. Gadjeva, D. M. Knipe, and M. C. Carroll Myeloid C3 Determines Induction of Humoral Responses to Peripheral Herpes Simplex Virus Infection J. Immunol., November 15, 2003; 171(10): 5363 - 5371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Pozdnyakova, H.-K. Guttormsen, F. N. Lalani, M. C. Carroll, and D. L. Kasper Impaired Antibody Response to Group B Streptococcal Type III Capsular Polysaccharide in C3- and Complement Receptor 2-Deficient Mice J. Immunol., January 1, 2003; 170(1): 84 - 90. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gadjeva, A. Verschoor, M. A. Brockman, H. Jezak, L. M. Shen, D. M. Knipe, and M. C. Carroll Macrophage-Derived Complement Component C4 Can Restore Humoral Immunity in C4-Deficient Mice J. Immunol., November 15, 2002; 169(10): 5489 - 5495. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
